On December 17, 2024, Gregory Bailey, a Director at Serina Therapeutics Inc (SER, Financial), purchased 3,866 shares of the company. Following this transaction, the insider now owns a total of 67,243 shares. The purchase was documented in an SEC Filing.
Serina Therapeutics Inc is a biotechnology company focused on the development of novel polymer therapeutics for the treatment of various diseases. The company utilizes its proprietary technology to create drug candidates that aim to improve the efficacy and safety of existing therapies.
The recent acquisition by Gregory Bailey is part of a broader trend of insider buying at Serina Therapeutics Inc. Over the past year, the insider has purchased a total of 66,973 shares and has not sold any shares. This activity is consistent with the overall insider transaction history for the company, which shows 15 insider buys and 0 insider sells in the past year.
Shares of Serina Therapeutics Inc were trading at $4.59 each on the day of the purchase, resulting in a market cap of $51.975 million for the company. Investors may consider this insider buying activity as a potential indicator of confidence in the company's future prospects.
For more information on the company's valuation metrics, such as GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, please visit the respective links.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
